biosimilar insulin aspart
Generic: Insulin Aspart
biosimilar insulin aspart: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LANNETT CO INC (LCI) | Preclinical |
Get deeper analysis on biosimilar insulin aspart
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis